Empresa Synairgen plc CINNOBER BOAT
Acciones
SNG
GB00B0381Z20
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Marsden
CEO | Chief Executive Officer | 57 | 01/11/03 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 06/11 |
Marcin Mankowski
CTO | Chief Tech/Sci/R&D Officer | - | 03/10/23 |
Jody Brooks
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/04 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/10/06 |
Richard Hennings
PRN | Corporate Officer/Principal | - | 01/03/21 |
Helen Gearing
PRN | Corporate Officer/Principal | - | 01/12/21 |
Gareth Walters
LAW | General Counsel | - | 13/10/21 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01/09/21 |
Simon Holden
SEC | Corporate Secretary | 48 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Simon Shaw
CHM | Chairman | 59 | 01/06/03 |
Stephen Holgate
FOU | Founder | 77 | 01/06/03 |
Richard Marsden
CEO | Chief Executive Officer | 57 | 01/11/03 |
David Campbell
BRD | Director/Board Member | 80 | 11/04/06 |
Felicity Gabbay
BRD | Director/Board Member | 72 | 29/09/22 |
Phillip Monk
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/10/06 |
Amanda Radford
BRD | Director/Board Member | 53 | 01/12/22 |
Joseph Colliver
DFI | Director of Finance/CFO | 43 | 06/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 201 374 975 | 195 153 037 ( 96,91 %) | 0 | 96,91 % |
Información de la empresa
Synairgen Plc
Mailpoint 810 Southampton General Hospital
SO16 6YD, Southampton
+44 23 8051 2800
http://www.synairgen.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,81 % | 46,81 mil M | |
+46,68 % | 41,29 mil M | |
-1,88 % | 41,37 mil M | |
-6,20 % | 28,87 mil M | |
+11,33 % | 26,06 mil M | |
-21,00 % | 19,13 mil M | |
-1,43 % | 11,96 mil M | |
+30,73 % | 12,39 mil M | |
-0,48 % | 12,08 mil M |